225 related articles for article (PubMed ID: 16714568)
1. Gamma interferon, tumor necrosis factor alpha, and nitric oxide synthase 2, key elements of cellular immunity, perform critical protective functions during humoral defense against lethal pulmonary Yersinia pestis infection.
Parent MA; Wilhelm LB; Kummer LW; Szaba FM; Mullarky IK; Smiley ST
Infect Immun; 2006 Jun; 74(6):3381-6. PubMed ID: 16714568
[TBL] [Abstract][Full Text] [Related]
2. Cell-mediated protection against pulmonary Yersinia pestis infection.
Parent MA; Berggren KN; Kummer LW; Wilhelm LB; Szaba FM; Mullarky IK; Smiley ST
Infect Immun; 2005 Nov; 73(11):7304-10. PubMed ID: 16239527
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection.
Philipovskiy AV; Smiley ST
Infect Immun; 2007 Feb; 75(2):878-85. PubMed ID: 17118978
[TBL] [Abstract][Full Text] [Related]
4. IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.
Lin JS; Kummer LW; Szaba FM; Smiley ST
J Immunol; 2011 Feb; 186(3):1675-84. PubMed ID: 21172869
[TBL] [Abstract][Full Text] [Related]
5. TNFα and IFNγ but not perforin are critical for CD8 T cell-mediated protection against pulmonary Yersinia pestis infection.
Szaba FM; Kummer LW; Duso DK; Koroleva EP; Tumanov AV; Cooper AM; Bliska JB; Smiley ST; Lin JS
PLoS Pathog; 2014 May; 10(5):e1004142. PubMed ID: 24854422
[TBL] [Abstract][Full Text] [Related]
6. Antibodies and cytokines independently protect against pneumonic plague.
Kummer LW; Szaba FM; Parent MA; Adamovicz JJ; Hill J; Johnson LL; Smiley ST
Vaccine; 2008 Dec; 26(52):6901-7. PubMed ID: 18926869
[TBL] [Abstract][Full Text] [Related]
7. Cell-mediated defense against Yersinia pestis infection.
Smiley ST
Adv Exp Med Biol; 2007; 603():376-86. PubMed ID: 17966434
[TBL] [Abstract][Full Text] [Related]
8. Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha.
Nakajima R; Brubaker RR
Infect Immun; 1993 Jan; 61(1):23-31. PubMed ID: 8418045
[TBL] [Abstract][Full Text] [Related]
9. Multiple antigen peptide containing B and T cell epitopes of F1 antigen of Yersinia pestis showed enhanced Th1 immune response in murine model.
Ali R; Naqvi RA; Kumar S; Bhat AA; Rao DN
Scand J Immunol; 2013 May; 77(5):361-71. PubMed ID: 23480362
[TBL] [Abstract][Full Text] [Related]
10. D27-pLpxL, an avirulent strain of Yersinia pestis, primes T cells that protect against pneumonic plague.
Szaba FM; Kummer LW; Wilhelm LB; Lin JS; Parent MA; Montminy-Paquette SW; Lien E; Johnson LL; Smiley ST
Infect Immun; 2009 Oct; 77(10):4295-304. PubMed ID: 19620344
[TBL] [Abstract][Full Text] [Related]
11. Induction of Type I Interferon through a Noncanonical Toll-Like Receptor 7 Pathway during Yersinia pestis Infection.
Dhariwala MO; Olson RM; Anderson DM
Infect Immun; 2017 Nov; 85(11):. PubMed ID: 28847850
[No Abstract] [Full Text] [Related]
12. Immune defense against pneumonic plague.
Smiley ST
Immunol Rev; 2008 Oct; 225():256-71. PubMed ID: 18837787
[TBL] [Abstract][Full Text] [Related]
13. Current challenges in the development of vaccines for pneumonic plague.
Smiley ST
Expert Rev Vaccines; 2008 Mar; 7(2):209-21. PubMed ID: 18324890
[TBL] [Abstract][Full Text] [Related]
14. Yersinia pestis YopE contains a dominant CD8 T cell epitope that confers protection in a mouse model of pneumonic plague.
Lin JS; Szaba FM; Kummer LW; Chromy BA; Smiley ST
J Immunol; 2011 Jul; 187(2):897-904. PubMed ID: 21653834
[TBL] [Abstract][Full Text] [Related]
15. Yersinia pestis V protein epitopes recognized by CD4 T cells.
Parent MA; Berggren KN; Mullarky IK; Szaba FM; Kummer LW; Adamovicz JJ; Smiley ST
Infect Immun; 2005 Apr; 73(4):2197-204. PubMed ID: 15784563
[TBL] [Abstract][Full Text] [Related]
16. Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague.
Elvin SJ; Williamson ED
Microb Pathog; 2004 Oct; 37(4):177-84. PubMed ID: 15458778
[TBL] [Abstract][Full Text] [Related]
17. Development of in vitro correlate assays of immunity to infection with Yersinia pestis.
Bashaw J; Norris S; Weeks S; Trevino S; Adamovicz JJ; Welkos S
Clin Vaccine Immunol; 2007 May; 14(5):605-16. PubMed ID: 17376861
[TBL] [Abstract][Full Text] [Related]
18. YopJ-promoted cytotoxicity and systemic colonization are associated with high levels of murine interleukin-18, gamma interferon, and neutrophils in a live vaccine model of Yersinia pseudotuberculosis infection.
Zhang Y; Bliska JB
Infect Immun; 2010 May; 78(5):2329-41. PubMed ID: 20231414
[TBL] [Abstract][Full Text] [Related]
19. Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis.
Honko AN; Sriranganathan N; Lees CJ; Mizel SB
Infect Immun; 2006 Feb; 74(2):1113-20. PubMed ID: 16428759
[TBL] [Abstract][Full Text] [Related]
20. YopP-expressing variant of Y. pestis activates a potent innate immune response affording cross-protection against yersiniosis and tularemia [corrected].
Zauberman A; Flashner Y; Levy Y; Vagima Y; Tidhar A; Cohen O; Bar-Haim E; Gur D; Aftalion M; Halperin G; Shafferman A; Mamroud E
PLoS One; 2013; 8(12):e83560. PubMed ID: 24358292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
